Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

1.

Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes.

Kaka AS, Shaffer DR, Hartmaier R, Leen AM, Lu A, Bear A, Rooney CM, Foster AE.

J Immunother. 2009 Sep;32(7):726-36. doi: 10.1097/CJI.0b013e3181ad4071. Erratum in: J Immunother. 2009 Nov-Dec;32(9):919. Hartmeier, Ryan [corrected to Hartmaier, Ryan].

PMID:
19561536
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.

Feder-Mengus C, Schultz-Thater E, Oertli D, Marti WR, Heberer M, Spagnoli GC, Zajac P.

Hum Gene Ther. 2005 Mar;16(3):348-60.

PMID:
15812230
[PubMed - indexed for MEDLINE]
3.

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.

Hum Immunol. 2004 Feb;65(2):142-56.

PMID:
14969769
[PubMed - indexed for MEDLINE]
4.

Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.

von Holzen U, Adamina M, Bolli M, Weber WP, Zajac P, Groeper C, Reschner A, Feder C, Schumacher R, Marti W, Oertli D, Heberer M, Spagnoli GC.

Int J Cancer. 2005 Jun 10;115(2):248-55.

PMID:
15688403
[PubMed - indexed for MEDLINE]
5.

Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.

Bae J, Martinson JA, Klingemann HG.

Clin Cancer Res. 2005 Feb 15;11(4):1629-38.

PMID:
15746068
[PubMed - indexed for MEDLINE]
Free Article
6.

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens.

Altvater B, Pscherer S, Landmeier S, Kailayangiri S, Savoldo B, Juergens H, Rossig C.

Cancer Immunol Immunother. 2012 Mar;61(3):385-96. doi: 10.1007/s00262-011-1111-6. Epub 2011 Sep 18.

PMID:
21928126
[PubMed - indexed for MEDLINE]
7.

Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.

Barbui AM, Borleri G, Conti E, Ciocca A, Salvi A, Micò C, Introna M, Rambaldi A.

Exp Hematol. 2006 Apr;34(4):475-85.

PMID:
16569594
[PubMed - indexed for MEDLINE]
8.

IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.

Liu Z, Liu JQ, Talebian F, Wu LC, Li S, Bai XF.

Eur J Immunol. 2013 Feb;43(2):468-79. doi: 10.1002/eji.201242930. Epub 2013 Jan 15.

PMID:
23225163
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K.

Int J Oncol. 2008 Sep;33(3):433-41.

PMID:
18695871
[PubMed - indexed for MEDLINE]
10.

alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.

Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.

Hum Immunol. 2007 May;68(5):334-41. Epub 2007 Feb 21.

PMID:
17462500
[PubMed - indexed for MEDLINE]
11.

Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma.

Morisaki T, Morton DL, Uchiyama A, Yuzuki D, Barth A, Hoon DS.

Cancer Immunol Immunother. 1994 Sep;39(3):172-8.

PMID:
7923247
[PubMed - indexed for MEDLINE]
12.
13.

Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.

Meij P, Bloemena E, Palmen N, Brink A, Vervoort MB, Meijer CJ, Middeldorp JM.

Cell Immunol. 2001 Feb 25;208(1):25-33.

PMID:
11277616
[PubMed - indexed for MEDLINE]
14.

CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

Suni MA, Ghanekar SA, Houck DW, Maecker HT, Wormsley SB, Picker LJ, Moss RB, Maino VC.

Eur J Immunol. 2001 Aug;31(8):2512-20.

PMID:
11500836
[PubMed - indexed for MEDLINE]
15.

Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.

Yu X, He J, Mongkhoune S, Peng Y, Xie Y, Su J, Zhou SF, Xie XX, Luo GR, Fang Y, Li X, Li X, Zhou N, Zhao YX, Lu XL.

Asian Pac J Trop Med. 2013 Jun;6(6):467-72. doi: 10.1016/S1995-7645(13)60076-0.

PMID:
23711708
[PubMed - indexed for MEDLINE]
16.

Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.

Bondurant KL, Crew MD, Santin AD, O'Brien TJ, Cannon MJ.

Clin Cancer Res. 2005 May 1;11(9):3446-54.

PMID:
15867247
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.

Xiaobing J, Xiaoling L, Ruen L, Fangcheng Z, Hongyang Z.

Cancer Biother Radiopharm. 2007 Dec;22(6):826-35.

PMID:
18158774
[PubMed - indexed for MEDLINE]
19.

IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.

Dubsky P, Saito H, Leogier M, Dantin C, Connolly JE, Banchereau J, Palucka AK.

Eur J Immunol. 2007 Jun;37(6):1678-90.

PMID:
17492620
[PubMed - indexed for MEDLINE]
20.

gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.

Walker EB, Haley D, Miller W, Floyd K, Wisner KP, Sanjuan N, Maecker H, Romero P, Hu HM, Alvord WG, Smith JW 2nd, Fox BA, Urba WJ.

Clin Cancer Res. 2004 Jan 15;10(2):668-80.

PMID:
14760090
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk